Výsledky vyhledávání - Kim Linton
- Zobrazuji výsledky 1 - 20 z 28
- Přejít na další stránku
-
1
-
2
A clinician’s guide to biosimilars in oncology Autor Hope S. Rugo, Kim Linton, P. Cervi, Julie A. Rosenberg, Ira Jacobs
Vydáno 2016Revisão -
3
Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single... Autor Adam Gibb, C. Jones, Adrian Bloor, S. Kulkarni, Tim Illidge, Kim Linton, John Radford
Vydáno 2012Artigo -
4
-
5
Spatial proximity between T and PD-L1 expressing cells as a prognostic biomarker for oropharyngeal squamous cell carcinoma Autor Anna Maria Tsakiroglou, Martin Fergie, Ken Oguejiofor, Kim Linton, David Thomson, Peter L. Stern, Susan Astley, Richard Byers, Catharine West
Vydáno 2019Artigo -
6
-
7
Guidelines for the diagnosis and management of primary central nervous system diffuse large B‐cell lymphoma Autor Christopher P. Fox, Elizabeth H. Phillips, Jeffery Smith, Kim Linton, Eve Gallop‐Evans, Claire Hemmaway, Dorothee P. Auer, Charlotte Fuller, Andrew Davies, Pam McKay, Kate Cwynarski
Vydáno 2018Revisão -
8
Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma Autor Alastair Greystoke, James P.B. O’Connor, Kim Linton, Malcolm Taylor, Jeffrey L. Cummings, Tim Ward, F Maders, Andrew Hughes, Malcolm Ranson, Tim Illidge, John Radford, Caroline Dive
Vydáno 2011Artigo -
9
Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours Autor Kim Linton, Y. Hey, Edward J. Saunders, Maria Jeziorska, J. Denton, Charles L. Wilson, R. Swindell, Siân Dibben, Crispin Miller, Stuart D Pepper, John Radford, Anthony J. Freemont
Vydáno 2008Artigo -
10
Drug-Induced Interstitial Lung Disease: A Systematic Review Autor Sarah Skeoch, Nicholas Weatherley, Andrew J. Swift, Alexander Oldroyd, Christopher Johns, Conal Hayton, Alessandro Giollo, Jim M. Wild, John C. Waterton, Maya H Buch, Kim Linton, Ian N Bruce, C.T. Leonard, Stephen Bianchi, Nazia Chaudhuri
Vydáno 2018Revisão -
11
Initial Findings from a First-in-Human Phase 1a/b Trial of NX-5948, a Selective Bruton's Tyrosine Kinase (BTK) Degrader, in Patients with Relapsed/Refractory B Cell Malignancies Autor Emma Searle, Francesco Forconi, Kim Linton, Alexey V. Danilov, Pam McKay, David John Lewis, Dima El‐Sharkawi, Mary Gleeson, John C. Riches, Sarah G. Injac, Ted Shih, Srinand Nandakumar, May Tan, Ganesh Cherala, Erin Meredith, Graham P. Collins
Vydáno 2023Artigo -
12
An Integrated Characterization of Serological, Pathological, and Functional Events in Doxorubicin-Induced Cardiotoxicity Autor Laura Cove-Smith, Neil Woodhouse, Adam Hargreaves, Jason Kirk, Susan M. Smith, Sally Price, Melanie Galvin, Catherine J. Betts, Simon Brocklehurst, Alison Backen, John Radford, Kim Linton, Ruth Roberts, Matthias Schmitt, Caroline Dive, Jonathan Tugwood, Paul Hockings, Howard R. Mellor
Vydáno 2014Artigo -
13
Early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma: long-term results of a randomised, phase 3 trial Autor Michael Northend, William Wilson, Kushani Ediriwickrema, Laura Clifton‐Hadley, Wendi Qian, Zaynab Rana, Tanya-Louise Martin, William Townsend, Moya Young, Fiona Miall, David Cunningham, Jan Walewski, Burhan Ferhanoğlu, Kim Linton, Amanda Johnston, John F. Seymour, David C. Linch, Kirit M. Ardeshna
Vydáno 2025Artigo -
14
Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study Autor Martin Hutchings, Rogier Mous, Michael Roost Clausen, Peter Johnson, Kim Linton, Martine E.D. Chamuleau, David John Lewis, Anna Sureda, David Cunningham, Roberto S Oliveri, Brian Elliott, Dena DeMarco, Ada Azaryan, Christopher Chiu, Tommy Li, Kuo-mei Chen, Tahamtan Ahmadi, Pieternella J. Lugtenburg
Vydáno 2021Artigo -
15
Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for Men Autor Hermann M. Behre, Michael Zitzmann, Richard A. Anderson, David J. Handelsman, Silvia Werdhy Lestari, Robert I. McLachlan, Maria Cristina Meriggiola, M. M. Misro, Gabriela Noé, Frederick C. W. Wu, Mario Festin, Ndema Habib, Kirsten M. Vogelsong, Marianne M. Callahan, Kim Linton, Doug Colvard
Vydáno 2016Artigo -
16
Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma Autor M. Dreyling, Franck Morschhauser, Krimo Bouabdallah, Dominique Bron, David Cunningham, Sarit Assouline, G. Verhoef, Kim Linton, Catherine Thiéblemont, Umberto Vitolo, Florian Hiemeyer, Marius Giurescu, J. Garcia‐Vargas, Igor Gorbatchevsky, Li Liu, Karl Koechert, Carol Peña, Manoel Martins das Neves, B.H. Childs, Pier Luigi Zinzani
Vydáno 2017Artigo -
17
Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B‐cell lymphoma of the central nervous system – an international study of feasibili... Autor Elisabeth Schorb, Christopher P. Fox, Benjamin Kasenda, Kim Linton, Nicolás Martínez‐Calle, Teresa Calimeri, Slavisa Ninkovic, Toby A. Eyre, Tom Cummin, Jeffery Smith, Deborah Yallop, Beatrice De Marco, Mauro Krampera, Stefan Trefz, Lorella Orsucci, Alberto Fabbri, Gerald Illerhaus, Kate Cwynarski, Andrés J.M. Ferreri
Vydáno 2020Artigo -
18
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP delivery Autor Matthew R. Wilson, Toby A. Eyre, Nicolás Martínez‐Calle, Matthew J. Ahearne, Katrina Parsons, Gavin Preston, Jahanzaib Khwaja, Jeremy Schofield, Johnathon Elliot, Almurtadha Mula kh, Nimish Shah, Cheuk-Kie Cheung, Matthew A. Timmins, Thomas Creasey, Kim Linton, Jeffery Smith, Christopher P. Fox, Fiona Miall, Kate Cwynarski, Pam McKay
Vydáno 2020Artigo -
19
Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and sur... Autor Nicolás Martínez‐Calle, Edward Poynton, Alia Alchawaf, Shireen Kassam, Matthew Horan, Mark Rafferty, P. Kelsey, Gemma Scott, Dominic Culligan, Hannah Buckley, Yeong Jer Lim, Loretta Ngu, Rory McCulloch, Clare Rowntree, Josh Wright, Pam McKay, Samih Fourali, Toby A. Eyre, Jeffrey A. Smith, Wendy Osborne, Deborah Yallop, Kim Linton, Christopher P. Fox, Kate Cwynarski
Vydáno 2020Artigo -
20
Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study Autor Stephen Opat, Alessandra Tedeschi, Bei Hu, Kim Linton, Pam McKay, Sophie Leitch, Morton Coleman, Pier Luigi Zinzani, Jie Jin, Mingyuan Sun, Magdalena Sobieraj‐Teague, Peter Browett, Xiaoyan Ke, Catherine Thiéblemont, Kirit M. Ardeshna, Fontanet Bijou, Patricia Walker, Eliza A. Hawkes, Shir‐Jing Ho, Keshu Zhou, Zhiyu Liang, Jianfeng Xu, Chris Tankersley, Richard Delarue, Melannie Co, Judith Trotman
Vydáno 2023Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Lymphoma
Oncology
Chemotherapy
Surgery
Biology
Rituximab
Adverse effect
Clinical trial
Gastroenterology
Pathology
Astrobiology
Cancer research
Diffuse large B-cell lymphoma
Neutropenia
Refractory (planetary science)
Cancer
Disease
Genetics
Methotrexate
Primary central nervous system lymphoma
Regimen
Autologous stem-cell transplantation
Biochemistry
Chemoimmunotherapy
Chronic lymphocytic leukemia
Clinical endpoint
Febrile neutropenia
Ibrutinib